Thursday, April 23, 2020 11:45:24 AM
Reading carefully through previous PRs will give you a lot of how this came about, but they have never shared whether they've tested 5 strips on 1 sample of blood or 100 test strips against 25 samples of blood.
Previously they shared that FDA told them they needed 30 dfferent blood samples if I recall correctly of venous blood which have been verified as coming from COVID-19 patients and others confirmed not being from COVID-19 patients in order to do their testing for the FDA EUA approval process.
So he is projecting complete confidence that the kits will pass the upcoming testing, but sure would be nice to know what that confidence is based on and share that with potential investors. There's no reason I can see to withhold that info as it would generate more interest than a Fortune 500 company being interested since the company's only interested if the test is really accurate and the FDA is warning people of non accurate tests.
You want this to skyrocket, reveal some hard core data on the test kit results. (if they are good, that is)
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM